Dorman (DORM) Q2 2025 Earnings Transcript

Dorman Products delivered a strong Q2 with net sales up 8% to $541 million, adjusted operating income up 12% to $88 million, and adjusted diluted EPS up 23% to $2.06. Management raised 2025 guidance to 7%-9% net sales growth and $8.60-$8.90 adjusted EPS, citing strong light-duty demand, new product launches, and tariff-related price actions. Offsetting the beat, operating cash flow fell sharply to $9 million from $63 million last year due to tariff costs and inventory investment, and heavy-duty/specialty segments remained pressured.

Analysis

DORM is one of the cleaner tariff winners in the industrials space because pricing can outrun cost recognition for a full quarter or more, creating a near-term gross margin air pocket in Q3 before the FIFO lag catches up in Q4. The market is likely underestimating how much of the raised EPS guide is timing rather than pure operating inflection; that makes the stock vulnerable to a late-year margin reset if investors extrapolate Q3 strength into 2026. The real fundamental signal is not the guide raise itself, but the combination of strong light-duty POS, low inventory distress, and continued mix shift toward higher-complexity parts that can sustain above-trend gross margin once the tariff noise washes through.

The competitive dynamic is asymmetric: Dorman’s diversified sourcing and OE-fix/new-to-aftermarket pipeline should pressure smaller competitors and import-heavy peers that lack pricing power or supply-chain flexibility. In heavy duty, however, the modest current margin profile means any recovery from the trucking trough can produce outsized incremental earnings, but that’s a months-to-years story, not a near-term catalyst. Specialty vehicle remains the weakest leg; if consumer borrowing conditions improve, that segment can snap back, but today it is a call option on macro stabilization rather than a core growth engine.

The key contrarian setup is that cash flow is the cleaner tell than EPS: inventory builds and tariff prepayments are temporarily masking earnings quality, and share repurchases have already been paused. If working capital normalizes into year-end while pricing sticks, the stock can re-rate higher; if tariffs escalate again or price increases lag channel adoption, the market will question the durability of the raised guide. The best risk/reward is to own the name into Q3 strength but treat Q4 as the first true test of whether this is margin expansion or just accounting timing.

Key Decisions for Investors

• Long DORM into Q3 print / October as a trade on tariff-driven price realization: upside to consensus if gross margin holds above expectations, but trim risk into Q4 when FIFO catches up and margins normalize.
• Buy DORM Jan-2026 calls or call spreads to express the view that 2025 guidance is conservative on top-line momentum; risk is compressed premium if Q4 cash conversion disappoints.
• Pair trade: long DORM / short an import-heavy auto-aftermarket peer with weaker pricing power and less supply-chain diversification; thesis is DORM’s tariff pass-through and mix advantage should outperform over the next 1-2 quarters.
• Watch for a tactical short entry in DORM on any post-earnings squeeze if investors start capitalizing Q3 margin strength as structural; Q4 is the likely fade point if inventory cost recognition hits as modeled.
• For longer-term capital, prefer a staggered add only if working capital and operating cash flow improve in the next update; if OCF stays suppressed, the EPS upgrade is lower quality than headline suggests.